The endothelin B receptor (ETBR) has been shown to mediate autoinduction of endothelin-1 (ET-1). We previously reported that the ETBR interacts with G 13, a member of the heterotrimeric GTP-binding protein family.
Introduction
Gα13, a member of the G12 family of guanine nucleotidebinding proteins (G-proteins), is ubiquitously expressed and regulates multiple complex cellular effects. Gα13 is activated by thrombin, thromboxane, thyroid-stimulating hormone, and angiotensin II AT1A receptors (1) (2) (3) (4) (5) . In addition, we previously demonstrated that endothelin B receptor (ETBR) activates Gα13 (6). Gα13 regulates Na/H exchanger activity (7, 8) , extracellular signal regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK) (9 -11), nuclear factor κB (NF-κB) (12) and the activity of the low molecular weight GTPase, Rho (13 -15) , and is also capable of neoplastic transformation, induction of apoptosis, and stimulation of actin reprotein kinases (ERK, JNK, and p38) (23, 24) . Because of its vasoconstrictor and growth-promoting action, numerous studies indicate that ET-1 is involved in the pathogenesis of a broad spectrum of renal and cardiovascular diseases (21, 22, (25) (26) (27) . Previous studies have demonstrated that ET-1 induced ET-1 production through ETAR and/or ETBR-mediated pathways, suggesting that a sustained ET-1 autocrine loop contributes to the progression of cardiovascular and renal diseases (28) (29) (30) (31) (32) .
ET and Gα13 share a number of effects on cells, including activation of JNK, the Na/H exchanger and Rho, and stimulation of cellular proliferation and differentiation (1, 7-11, 13-15, 21, 23, 24, 33-38) . We previously demonstrated that ETBR activates Gα13 (6) . In the present study, we have examined whether Gα13 could activate the preproET-1 (ppET-1) gene promoter to take part in the ET-1 autoinduction loop. We show that the activated Gα13 is able to induce ppET-1 gene expression via JNK dependent pathway.
Methods

Materials
COS-7 cells were obtained from the American Type Culture Collection (Rockville, USA). Tissue culture medium and fetal bovine serum (FBS) were obtained from GIBCO-BRL (Rockville, USA); ET-1 from Calbiochem (San Diego, USA); restriction and DNA modifying enzymes from GIB CO-BRL or TaKaRa (Kusatsu, Shiga, Japan); and tissue culture plastic wares from Falcon (Becton Dickinson Labware, Bedford, USA).
Cell Culture
COS-7 cells were grown in Dulbecco's modified Eagle's medium with 10% FBS in a 10% CO2-90% air incubator. Culture medium was replaced every 3 days. Cells were passed using 0.01% ethlylenediamine tetraacetic acid (EDTA)-trypsin.
Plasmids
A 2.6 kb fragment of human ET-1 promoter region (from 2456 to 168, a gift from G.A. Visner, University of Florida, Gainesville, USA) (39) was subcloned into a luciferase reporter plasmid, pGL3 basic (Promega, Madison, USA). The cDNA encoding the human ETBR was a gift form M Yanagisawa (University of Texas Southwestern Medical Center, Dallas, USA) (40) . The cDNA constructs of αsQ227L, αi2Q205L, α13Q226L, and αqQ209L were described previously (8, 41, 42 ). An expression construct of a dominant negative form of c-Jun N-terminal kinase (JNK1APF) was provided by GL Johnson (University of Colorado, Denver, USA) (43) and a cDNA coding for the dominant negative form of MAPK/ERK kinase (MEKK97M) was a gift from MH Cobb (University of Texas Southwestern Medical Center, Dallas, USA). cDNAs were subcloned into pcDNA3 (Invitrogen, Carlsbad, USA). The sequence of the resulting construct was confirmed using restriction and sequencing analysis.
Transfection and Luciferase Assay
COS-7 cells (4.0 10 5 cells/well) were seeded the day before transfection in 6-well plates. The cells were transfected using the Ca-PO4 co-precipitation method. Each transfection mixture contained 0.25 µg of a reporter construct and 0.5 µg of other cDNA construct(s) as indicated. The total amount of transfected DNA was adjusted to 2 µg by adding an empty vector, pcDNA3.
After incubating the cells with DNA/Ca-PO4 precipitates for 4-6 h at 37ºC, the cells were washed three times with phosphate buffered saline, and incubated with Dulbecco's modified eagle medium (DMEM) containing 0.2% FBS. The transfected cells were harvested 48 h after transfection. Where indicated, ET-1 (100 nmol/l) were added 24 h before the harvest. Luciferase activity was measured using a Luciferase Assay System (Promega) and a TD-20/20 Luminometer (Turner Designs, Sunnyvale, USA) according to the manufacturer's instruction.
Statistical Analysis
Statistical significance was evaluated using the two-tailed, unpaired Student's t-test for comparisons between 2 means, or analysis of variance (ANOVA) analysis followed by the Newman-Keuls method for more than 2 means. A value of 
Results
The ETBR Activates ppET-1 Promoter Following ET-1 Treatment in COS-7 Cells
Previous studies have demonstrated ETBR-mediated autoinduction of ET-1 in endothelial and mesangial cells (29 -31) . However, in a study of human keratinocytes, ET-1 treatment decreased ET-1 production presumably through ETBR (44), suggesting that ETBR-mediated induction of ET-1 may be cell type-dependent. In the current study, we examined whether activation of ETBR induces ppET-1 gene expression in COS-7 cells. The ETBR was transiently expressed, and ET-1 (100 nmol/l) was added to the culture medium 24 h after transfection. Transfected cells were harvested 48 h after transfection and luciferase activity was measured. As shown in Fig. 1 , treatment with 100 nmol/l ET-1 increased ppET-1 transcription by approximately 2.5-fold in COS-7 cells expressing ETBR, while expression of ETBR itself had no significant effect on ppET-1 promoter activity. These data indicate that ET-1 is able to induce ppET-1 transcription through the activation of ETBR in COS-7 cells.
The Effects of Constitutively Active G-Protein Subunits on ppET-1 Promoter Activity
The ETBR is known to activate G-proteins that are members of the Gαi, Gαq, Gαs and Gα12 families (6) . To investigate which G-protein α subunit family is responsible for the activation of ppET-1 gene transcription through the ETBR, we coexpressed constitutively active forms of four α subunits, Gα13 (α13Q226L), Gαq (αqQ209L), Gαs (αsQ227L) or Gαi2 (αi2Q205L), and the ppET-1 promoter construct in COS-7 cells. Luciferase activity was measured 48 h after transfection. Expression of α13Q226L and αqQ209L increased ppET-1 promoter activity with similar potency, while αsQ227L and αi2Q205L had no effect on the ppET-1 transcription (Fig. 2) . These results indicate the possibility that Gα13-and/or Gαq-coupled signaling systems might be involved in the ETBR-mediated autoinduction of ET-1.
Fig. 2. G-protein-mediated activation of ppET-1 promoter. COS-7 cells were transfected with a ppET-1 promoter/luciferase construct and pcDNA3 encoding Gα13Q226L, GαqQ209L, GαsQ225L or Gαi2Q207. Forty-eight hours after transfection, luciferase activity was assayed. Values are the fold-increase over the control and expressed as the mean SEM (n 5).
p 0.05.
Fig. 3. Involvement of JNK-and MEK-dependent pathways in ETBR-mediated ppET-1 promoter activation. COS-7 cells were transfected with a ppET-1 promoter/luciferase construct and ETBR in the presence or absence of either JNK1APF or MEKK97M. Twenty-four hours after transfection, cells were treated with 100 nmol/l ET-1 for 24 h. Then cells were harvested and assayed for luciferase activity. Values are the fold-increase over the control and expressed as the mean SEM (n 4). p 0.05.
Fig. 4. Involvement of JNK in Gα13-mediated ppET-1 promoter activation. COS-7 cells were transfected with a ppET-1 promoter/luciferase construct and Gα13Q226L with or without JNK1APF. Cells were harvested 48 h after transfection and luciferase activity was measured. Values are the fold-increase over the control and expressed as the mean SEM (n 6). p 0.05.
Involvement of a JNK-Dependent Signaling Pathway in the Activation of ppET-1 Promoter through ETBR and G 13
Since the ETBR activates multiple signaling pathways including JNK and MEK, we investigated the involvement of JNK-and MEK-dependent pathways in ETBR-induced ppET-1 promoter activation. COS-7 cells were transiently transfected with ETBR in the presence or absence of either the JNK1APF or MEK (MEKK97M) expression vectors. ET-1 (100 nmol/l) was added to the culture media 24 h before harvest and reporter gene activity was measured 48 h after transfection. Figure 3 shows that expression of JNK1APF or MEKK97M partially inhibited ppET-1 promoter activity following the ETBR stimulation. These findings strongly demonstrate that both JNK-and MEK-dependent signaling pathways are involved in the autoinduction of ET-1 through ETBR. Next, we examined the effect of dominant negative JNK on Gα13-induced activation of the ppET-1 promoter, since Gα13 activates JNK-dependent pathways in a variety of cells. As shown in Fig. 4 , expression of JNK1APF partially blocked the Gα13Q226L-induced ppET-1 promoter activity in COS-7 cells. Taken together, our results suggest that autoinduction of ET-1 through ETB receptor activation involves a Gα13-dependent signaling system that is partially mediated by JNK in COS-7 cells.
Discussion
In the present study, we demonstrated that activated ETBR and constitutively active forms of Gα13 as well as Gαq activate ppET-1 gene transcription in COS-7 cells. Activation of ppET-1 promoter by Gα13 was partially mediated by a JNKdependent pathway. ETBR activated Gα13 when they were co-expressed in HEK293 cells (6) . Taken together, our previous and current results suggest a role of Gα13 in ETBR-mediated ET-1 autoinduction and other ET-1-mediated pathophysiological reactions. It is well known that endothelin production is up-regulated by various stimuli such as TGF-β, tumor necrosis factor (TNF)-α, interleukins, insulin, norepinephrin, angiotensin II (via AT1 receptors), thrombin, and other physicochemical factors (22, 23, 27) . Since Gα13 interacts with AT1 receptors and thrombin receptors (3, 5) , Gα13 could play an important role in induction of endothelin by these peptides. Recently, Offermanns and associates showed that a dominant negative form of Gα13 prevented ET-1-mediated vascular smooth muscle cell (VSMC) contraction in vitro and that intracellular injection of activated Gα13 evoked VSMC contraction (45) , which suggests the involvement of Gα13 not only in the regulation of ET-1 production, but also in a broad range of ET-1 bioactivities, including vascular tone regulation.
In our system, Gα13 induces ET-1 transcription presumably through activating protein (AP-1). Because activation of a small GTPase, Rho, is one of the downstream consequences of Gα13 activation (13) (14) (15) , and because a recent study demonstrated that Rho activates the ppET-1 promoter in bovine aortic endothelial cells (46) , Rho might be involved in the autoinduction of ET-1 that is mediated by Gα13. Moreover, since Gαq has been shown to activate JNK and Rho (47, 48) , it is likely that Gαq induces ET-1 production not only through protein kinase C (PKC)-mediated pathways but also through JNK and/or Rho. Further studies are needed to elucidate the contribution of the Rho-dependent signaling system in the JNK-mediated autoinduction of ET-1 in our system.
We previously demonstrated that ETAR does not activate Gα13 (6) . A previous study reported that a blockade of ETAR that was able to activate Gαq did not inhibit ET-1 production stimulated by ET-1 in rat mesangial cells (29) . On the other hand, in a study using a rat model of congestive heart failure, the ETAR antagonist BQ-123 normalized the increased expression level of ppET-1 mRNA (32) . In addition, the constitutively active form of Gαi2 was not able to increase ppET-1 promoter activity in our system, although Gαi2 has been demonstrated to activate JNK and Rho in HEK293 cells (49) . These results suggest that the nature of the signaling pathways involved in the autoinduction of ET-1 may vary in different tissues.
In conclusion, we demonstrated that Gα13 induces ppET-1 promoter activation partially through a JNK dependent pathway in COS-7 cells, which suggests a possible role of Gα13 in ET-1 autoinduction. Further investigation is required to complete the picture of the ET-1 autoinduction pathways and G-protein-mediated signaling cascades that are downstream of ET receptors.
